Takeda

MAZUREK Study

Evaluation of long-term effects of biological treatment
in patients with ulcerative colitis in Poland.

NON-INTERVENTIONAL OBSERVATIONAL STUDY.

Dear Doctors,

We invite you to participate in a multicenter observational study titled: "Evaluation of long-term effects of biological treatment in patients with ulcerative colitis in Poland", whose primary objective is to determine the rate of loss of response after completion of biological treatment in patients with ulcerative colitis.

The obtained results may help determine the optimal time for biological treatment of ulcerative colitis, thereby increasing the chances of patients with ulcerative colitis to have access to optimal treatment time.

To start the study, it is necessary to conclude an online agreement. Therefore, please register and follow the instructions appearing on the computer screen.

BioStat® company oversees the smooth course of the study and data analysis.

All inquiries should be directed to the Organizer's office.

BioStat Sp. z o.o.
Kowalczyka 17, 44-206 Rybnik
tel: 666 069 814
email: [email protected]

BioStat

Please fill out the registration form and join the study.

Registration form

Study sponsor

Takeda Pharma sp. z o.o.
Prosta 68, 00-838 Warsaw, Poland
tel: +48 22 608 13 00/01
fax: +48 22 608 13 03

PL/EYV/19/0077

Please log in using the data obtained after concluding the online agreement.